Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy
about
Perinatally infected adolescents living with human immunodeficiency virus (perinatally human immunodeficiency virus)A normal reference of bone mineral density (BMD) measured by dual energy X-ray absorptiometry in healthy thai children and adolescents aged 5-18 years: a new reference for Southeast Asian PopulationsLower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.Bone health in HIV-infected children, adolescents and young adults: a systematic review.Efavirenz is associated with higher bone mass in South African children with HIV.Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.Bone health in children and adolescents with perinatal HIV infectionMetabolic complications and treatment of perinatally HIV-infected children and adolescents.Adverse bone health among children and adolescents growing up with HIV.Prevalence of vitamin D deficiency among perinatally HIV-infected Thai adolescents receiving antiretroviral therapyContraceptive options for HIV-positive women: making evidence-based, patient-centred decisions.Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life.Effect of calcium and vitamin D supplementation on bone mineral accrual among HIV-infected Thai adolescents with low bone mineral density.The 16th Bangkok International Symposium on HIV Medicine
P2860
Q26797775-8266EFE4-AC91-4911-8564-E66F280886B6Q33644384-A49C6D1A-6606-4BC2-8D83-A57A206AF449Q35659264-99D3622E-B750-4BFC-86E2-851E9B2DB015Q35822412-2BA97DA7-D511-4C76-9B61-766CF5991AF7Q36079798-429E72D9-1EB4-4D5D-9BEF-1BC714EDFA0FQ36091261-2B11A00E-785D-4556-B184-FE15765855F2Q36311433-B65C1FBA-F9FF-4EB5-84AC-05FE4F0FD0FDQ36941665-6AF497E0-8DC6-4D5C-87A4-2A54151B4909Q36941678-5CB7023A-862E-4BB4-BA45-A0971237549EQ36952291-B8201F78-712B-4682-AE01-46BC849007BDQ37098360-8A587B6E-61EB-4D8A-9037-F7FE1D968E62Q37249960-D0EED450-0375-4F8C-9A8D-76E4031AA6DDQ38358383-C34B1ABD-E160-4B0F-9B3C-77E1FB10C9C1Q40203598-6EADB842-5AB6-41A1-9989-84468C724F2AQ54250402-DE173D5A-1854-4B36-9558-45BE84343CB6Q58815106-C1BC1EA9-AF3A-4E9C-B676-E5A3CE8B4E53
P2860
Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prevalence and risk factors of ...... ceiving antiretroviral therapy
@ast
Prevalence and risk factors of ...... ceiving antiretroviral therapy
@en
type
label
Prevalence and risk factors of ...... ceiving antiretroviral therapy
@ast
Prevalence and risk factors of ...... ceiving antiretroviral therapy
@en
prefLabel
Prevalence and risk factors of ...... ceiving antiretroviral therapy
@ast
Prevalence and risk factors of ...... ceiving antiretroviral therapy
@en
P2093
P2860
P921
P1476
Prevalence and risk factors of ...... ceiving antiretroviral therapy
@en
P2093
Alan Maleesatharn
Kulkanya Chokephaibulkit
Orasi Wittawatmongkol
Pairunyar Nakavachara
Rachanee Saksawad
Sasiwimol Ubolyam
Tawatchai Chaiwatanarat
Thanyawee Puthanakit
Thongsuai Chuanjaroen
Torsak Bunupuradah
P2860
P304
P356
10.1097/QAI.0B013E31826EA89B
P407
P577
2012-12-01T00:00:00Z